Sabby Management’s TuHURA Biosciences HURA Stock Holding History

Sabby Management’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-701	Closed	-$153K	–	109
2019 Q4	$153K	Buy	701 +157	+29%	+$169K	0.04%	54
2019 Q3	$526K	Buy	+544	New	+$1.02M	0.28%	35
2019 Q2	–	Sell	-28	Closed	-$243K	–	110
2019 Q1	$243K	Sell	28 -53	-65%	-$360K	0.12%	46
2018 Q4	$488K	Buy	+81	New	+$786K	0.11%	56
2017 Q4	–	Sell	-121	Closed	-$1.78M	–	188
2017 Q3	$1.78M	Buy	121 +84	+227%	+$2.3M	0.12%	57
2017 Q2	$1.48M	Buy	+37	New	+$1.66M	0.1%	85

Other funds holding HURA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sabby Management's HURA Position: Q1 2020 in Review

Sabby Management sold out of TuHURA Biosciences (HURA) in Q1 2020, closing a stake of 701 shares — an estimated $153K sold.

Sabby Management first reported a position in HURA in Q2 2017 and held it in 6 quarters. The position peaked at $1.78M in Q3 2017. 5 funds tracked by Wall St. Rank hold HURA as of Q1 2020.

Sabby Management reported no remaining TuHURA Biosciences position as of Q1 2020 after selling out during the quarter.
Sabby Management sold 701 TuHURA Biosciences shares in Q1 2020, an estimated $153K.
Sabby Management first reported a position in TuHURA Biosciences in Q2 2017 and held it in 6 quarters.
Sabby Management's TuHURA Biosciences position peaked at $1.78M in Q3 2017.
5 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2020.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.